Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated the safety, efficacy, and pharmacokinetics of combining capecitabine with exisulind in metastatic breast cancer. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exisulind (exisulind)
• Xeloda (capecitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Neoplasms, Metastases, Neoplasm | Phase 1, Phase 2 | Status: COMPLETED